Book & podcast collection

Off the Scales: The Inside Story of Ozempic and the Race to Cure Obesity

★ 2026 Financial Times and Standard Chartered Business Book of the Year — Longlist ★ 2026 Financial Times and Standard Chartered Business Book of the Year — Shortlist

Aimee Donnellan traces the research, commercial competition, and personal experiences behind the rise of Ozempic and related medicines. Her reporting follows scientists whose work enabled GLP-1 drugs, including a researcher whose contributions received too little recognition, and people who became early users. The book considers how these treatments are changing the pharmaceutical industry while unsettling food businesses, beauty ideals, and familiar assumptions about body weight. Connecting scientific discovery with questions of access, stigma, and inequality, Donnellan examines both the promise of a medical breakthrough and the difficult social choices accompanying it.

Publisher: St. Martin's Press
Publication date: 2025-11-18
Format: Hardcover
Pages: 320
ISBN: 9781250389060

Subjects

Business & Economics: Industries – Pharmaceutical & Biotechnology Business & Economics: Industries – Healthcare

Choose a subject to discover similar books and author interviews.

Buy on Amazon Buy on Bookshop.org Publisher website

Listen now

Interview with the Author

3 available interview links

1. The Pat Kenny Show — Off the scales:The Inside Story Of Ozempic And The Race To Cure ObesityChecked

No verified Spotify link found.

2. The Women's Podcast — Beckham family feud / The inside story of OzempicChecked

Listen on Spotify ↗

3. Nutrition Science Bites with Professor Clare Collins AO — "Off the Scales - The Inside Story of Ozempic" ...with Reuters Journalist Aimee DonnellanChecked

No verified Spotify link found.